Literature DB >> 6273230

A new sequence-specific endonuclease from Streptococcus durans.

A Janulaitis, L Marcinkeviciene, M Petrusyte, A Mironov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273230     DOI: 10.1016/0014-5793(81)80594-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

1.  Nomenclature for incompletely specified bases in nucleic acid sequences. Recommendations 1984. Nomenclature Committee of the International Union of Biochemistry (NC-IUB).

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  BmyI, a novel SduI isoschizomer from Bacillus mycoides recognizing 5'-GDGCH/C-3'.

Authors:  E Wagner; G G Schmitz; K Kaluza; M Jarsch; F Götz; C Kessler
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

3.  Restriction enzymes and their isoschizomers.

Authors:  R J Roberts
Journal:  Nucleic Acids Res       Date:  1989       Impact factor: 16.971

4.  Nomenclature for incompletely specified bases in nucleic acid sequences: recommendations 1984.

Authors:  A Cornish-Bowden
Journal:  Nucleic Acids Res       Date:  1985-05-10       Impact factor: 16.971

5.  Restriction and modification enzymes and their recognition sequences.

Authors:  R J Roberts
Journal:  Nucleic Acids Res       Date:  1985       Impact factor: 16.971

6.  Restriction enzymes and their isoschizomers.

Authors:  R J Roberts
Journal:  Nucleic Acids Res       Date:  1988       Impact factor: 16.971

7.  Nomenclature Committee of the International Union of Biochemistry (NC-IUB). Nomenclature for incompletely specified bases in nucleic acid sequences. Recommendations 1984.

Authors: 
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus live recombinant microbicides.

Authors:  Misaki Wayengera; Henry Kajumbula; Wilson Byarugaba
Journal:  Theor Biol Med Model       Date:  2008-08-07       Impact factor: 2.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.